Covid vaccine: Chinese COVID-19 vaccine candidate shows promise in human trial: Study


Source: indiatimes.com indiatimes.com

Key Topics in this News Article:

News Snapshot:

BEIJING: One of China's leading COVID-19 vaccine candidates , called BBIBP-CorV , was shown to be safe and elicited immune response in a small early-phase human trial , researchers said on Friday. A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients. Participants aged 60 and over...